Focused prevention and treatment of noncommunicable diseases may reduce the burden of multimorbidity in people living with HIV who have mood disorders and multimorbidity.
Researchers studied the average age of menopause, prevalence of early menopause and premature menopause, and correlates of menopause occurring at <45 years in women living with HIV.
Symtuza is a 4-drug combination of darunavir, an HIV-1 protease inhibitor; cobicistat, a CYP3A inhibitor; and emtricitabine and tenofovir alafenamide.
Most have regular doctor, but few have had conversations about same-sex sexual behaviors, HIV testing.
NIH-sponsored trial was being conducted in South Africa.
Integrase strand transfer inhibitors (INSTIs) are a generally well-tolerated class of antiretrovirals that have a higher antiviral potency compared with other classes of ART.
Effective implementation of HIV prevention strategies begins with appropriate patient-clinician communication, and one of the most important things a nurse practitioner and physician assistant can do is normalize the conversation.
Number of HIV-2 diagnoses remains low; more false positives seen with greater use of differentiation test.
Data published in JAMA Network Open suggest that prescribing practices for ART in pregnant women living with HIV in the US do not align optimally with national guidelines.
A substantial number of HIV infections are likely attributable to pre-existing infection with the herpes simplex virus type 2.
Similar proportion of infants attain, sustain viral suppression when starting <48 hours, 2 to 14 days after birth.
Administration of simeprevir is more problematic with ART; sofosbuvir has fewest interactions with ART.
Many prescribed ARVs with insufficient evidence, not recommended for use in pregnant women with HIV.
Alendronate treatment is well-tolerated and improved bone mineral density (BMD) with no safety concerns in children and adolescents with perinatally acquired HIV.
Safety and efficacy of isoniazid for the prevention of tuberculosis may vary between HIV-infected pregnant and postpartum women.
According to the United States Centers for Disease Control and Prevention’s Morbidity and Mortality Weekly Report, preliminary data from 2017 show that gay, bisexual, and other men who have sex with men accounted for 67% of incident diagnoses of HIV.
Of the estimated 38,739 new cases of HIV reported in 2017, 70% were among men who have sex with men. Use of daily PrEP can virtually eliminate the risk of developing HIV, if used as prescribed.
In women with HIV, lower education and hepatitis C co-infection are independently associated with the onset of menopause before age 45 years.
Distribution of HIV self-tests among men who have sex with men can increase testing and newly identified infections.
The test may help clinicians tailor HIV therapy for their patients.